Literature DB >> 2699001

Patient compliance with therapeutic advice: a modern view.

R H Fletcher.   

Abstract

Considering all the hurdles between the advice to take medication and the taking of it, that patients comply as well as they do is remarkable. It is all the more remarkable when physicians ask patients who are well to take costly and unpleasant medications or diets (for example, for hypertension or hyperlipidemia), day after day, to prevent low-probability events many years in the future. The problem of noncompliance will remain with us; it is, after all, part of the human condition. It will not be, and probably should not be, conquered altogether. Because many prescribed medications are not powerful over and above their placebo effects, noncompliance often does no harm. When patients refuse to do what physicians advise, as expressions of their own informed free will, it is also unclear that harm has been done. What we, as a health-care community, should be most concerned about is the noncompliance that arises for other, less ambiguous reasons: failure of communication or lack of opportunity. The main issue, as I see it, is to find ways to reduce unnecessary and harmful noncompliance--that is, noncompliance that occurs because of misunderstanding about what has been suggested and what is at stake, or because of poverty and other logistic problems. Therefore, I have emphasized those aspects of compliance in this review. Compliance with medical advice is far too complex, especially these days, to reduce to a simple yes-no dichotomy. A great deal of wisdom is called for, both on the patient's and on the physician's side, when medical advice is given.

Entities:  

Keywords:  Professional Patient Relationship

Mesh:

Year:  1989        PMID: 2699001

Source DB:  PubMed          Journal:  Mt Sinai J Med        ISSN: 0027-2507


  3 in total

Review 1.  Patient compliance and medical research: issues in methodology.

Authors:  J Melnikow; C Kiefe
Journal:  J Gen Intern Med       Date:  1994-02       Impact factor: 5.128

2.  Clinician's perspectives on the treatment of venous leg ulceration.

Authors:  George H Cullen; Tania J Phillips
Journal:  Int Wound J       Date:  2009-10       Impact factor: 3.315

3.  Factors associated with adherence and persistence to bisphosphonate therapy in osteoporosis: a cross-sectional survey.

Authors:  A J Carr; P W Thompson; C Cooper
Journal:  Osteoporos Int       Date:  2006-08-01       Impact factor: 4.507

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.